Inhibitors of epithelial–mesenchymal transition (EMT) significantly reduced the excessive proliferation, migration, and invasive behavior of RA-FLs by a reduction in MMP1, -3, and -13 secretion. The gene discussed is MMP1; the disease is rheumatoid arthritis.